Biden to lower some drug costs through inflation penalties

Biden to lower some drug costs through inflation penalties

US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023.  Chris Kleponis | Bloomberg | Getty Images The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs … Read more

Novo Nordisk’s Wegovy weight loss drug approved in China

Novo Nordisk’s Wegovy weight loss drug approved in China

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” … Read more

Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility

Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility

Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies.  Demand for … Read more

Eli Lilly expects FDA decision on Zepbound for sleep apnea as early as end of year

Eli Lilly expects FDA decision on Zepbound for sleep apnea as early as end of year

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive … Read more

Weight loss drug contender Zealand Pharma jumps 23% on trial results

Weight loss drug contender Zealand Pharma jumps 23% on trial results

Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024.  Bloomberg | Bloomberg | Getty Images LONDON — Shares of Denmark’s Zealand Pharma popped nearly 23% in Friday morning deals, notching a record high after an early-stage study of its weight loss drug challenger produced … Read more

FDA approves Merck pneumococcal disease vaccine designed for adults

FDA approves Merck pneumococcal disease vaccine designed for adults

Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. Merck’s shot, called Capvaxive, specifically protects against 21 strains … Read more

Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s

A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023.  George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights over the last year. … Read more

Judge bars Martin Shkreli from streaming Wu-Tang Clan album

Judge bars Martin Shkreli from streaming Wu-Tang Clan album

Former drug company executive Martin Shkreli and his lead attorney Benjamin Brafman arrive at U.S. District Court for the fourth day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 3, 2017.  Amr Alfiky | Reuters A federal judge temporarily barred notorious “pharma bro” Martin Shkreli … Read more

Eli Lilly’s Alzheimer’s drug could help stock join the $1 trillion club

Eli Lilly’s Alzheimer’s drug could help stock join the  trillion club

Eli Lilly became the most valuable health-care company in the world on the back of its blockbuster diabetes and obesity drugs. To join the $1 trillion market capitalization club, it will need help from the bench — including an Alzheimer’s drug that moved one step closer to market this week. A key advisory panel for … Read more

FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab

FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty … Read more